Source comparison
Loading Phase vs Maintenance Dosing Strategy
Most effective TB-500 tendon healing protocols use a biphasic approach: a loading phase (weeks 1–4) with higher frequency and dose, followed by a maintenance phase (weeks 5–8) at reduced frequency. The loading phase targets the inflammatory-to-proliferative tr
This comparison does not assign a generated winner or score.
- Most effective TB-500 tendon healing protocols use a biphasic approach: a loading phase (weeks 1–4) with higher frequency and dose, followed by a maintenance phase (weeks 5–8) at reduced frequency. The loading phase targets the inflammatory-to-proliferative transition, when fibroblast migration and angiogenesis are most active. Typical loading protocols use 5mg twice weekly (Monday/Thursday or Tuesday/Friday) for the first 4 weeks.
- Maintenance dosing. Employed after the acute proliferative phase. Often drops to 2–3mg twice weekly or 5mg once weekly. Research models using this approach showed that abrupt cessation after 4 weeks resulted in rebound inflammation in 18–22% of cases, while gradual dose reduction maintained healing trajectory without adverse events. A veterinary study published in the American Journal of Veterinary Research found that horses with superficial digital flexor tendon injuries receiving 6 weeks of TB-500 at reducing doses (10mg twice weekly for 3 weeks, then 10mg weekly for 3 weeks) demonstrated better long-term tendon integrity on ultrasound at 6 months compared to 4-week-only protocols.
- Here's the honest answer: the evidence for specific maintenance schedules in human-equivalent models is limited. Most published research uses acute injury models with 4–6 week observation windows. Long-term maintenance beyond 8 weeks remains largely empirical, guided by anecdotal veterinary use rather than controlled trials. If you're designing a research protocol, document dosing decisions rigorously. The field needs this data.